瘦素基因多态性与非酒精性脂肪性肝病及胰岛素抵抗的相关性
被引量:3
摘要
非酒精性脂肪性肝病(NAFLD)的发病与胰岛素抵抗相关。瘦素是一种能量平衡的调节激素,其主要作用是控制食物摄人和调节能量代谢。瘦素水平与肝脂肪变的严重程度和肝纤维化相关,本研究通过检测广州市城区居民NAFLD和正常人瘦素启动子区2548位的基因型和血浆中瘦素水平,探讨其与胰岛素抵抗及NAFLD的相关性。
出处
《中华消化杂志》
CAS
CSCD
北大核心
2008年第2期126-127,共2页
Chinese Journal of Digestion
参考文献9
-
1中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊断标准[J].中华肝脏病杂志,2003,11(2):71-71. 被引量:1366
-
2Mammes O, Betoulle D, Aubert R, et al. Association of the G-2548A polymorphism in the 5'region of the LEP gene with overweight. Ann Hum Genet, 2000, 64:391-394.
-
3Jiang Y, Wilk JB, Borecki I, et al. Common variants in the 5'region of the leptin gene are associated with body mass index in men from the National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet, 2004, 75:220-230.
-
4Hsueh WC, Mitchell BD, Schneider JL, et al. Genome-wide scan of obesity in the Old Order Amish. J Clin Endocrinol Metab, 2001, 86:1199-1205.
-
5Mammes O, Betoulle D, Aubert R, et al. Novel polymorphisms in the 5'region of the LEP gene: association with leptin levels and response to low-calorie diet in human obesity. Diabetes, 1998, 47:487-489.
-
6张志珺,姚志剑,牟晓冬,陈建芳,朱荣鑫,刘文,张向荣,孙静,侯钢.瘦素基因启动子区-2548G/A功能多态性与抗精神病药源性肥胖的相关分析[J].中华医学杂志,2003,83(24):2119-2123. 被引量:15
-
7Tsochatzis E, Papatheodoridis GV, Archimandritis AJ. The evolving role of leptin and adiponectin in chronic liver diseases. Am J Gastroenterol, 2006, 101:2629-2640.
-
8Marchesini G, Marzocchi R, Agostini F, et al. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol, 2005, 16:421-427.
-
9Tilg H, Hotamisligil GS. Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology, 2006, 131:934-945.
二级参考文献15
-
1Mammes O, Betoulle D, Aubert R, et al. Novel polymorphis ms in the 5′ region of the LEP gene: association with leptin levels and response to low- calorie diet in human obesity. Diabetes, 1998, 47: 487-489.
-
2Le Stunff C, Bihan CL, Schork NJ, et al. A common promoter variant of the leptin gene is associated with changes in the relationship between serum leptin and fat mass in obese girls. Diabetes, 2000, 49: 2196-2200.
-
3Hoffstedt J, Eriksson P, Mottagui-Tabar S, et al. A polymorphism in the leptin promoter region (-2548G/A) in fluences gene expression and adipose tissue secretion of leptin. Horm Metab Res, 2002, 34: 355-359.
-
4Ko GT, Tang J, Chan JC, et al. Lower BMI cut-off value to define obesity in Hong Kong Chinese: an analysis based on body fat assessment by bioelectrical impedance. Br J Nutrition, 2001, 85: 239-242.
-
5Seidell JC, Bakker CJ, van der Kooy K. Imaging techniques for measuring adipose-tissue distribution--a comparison between computed tomography and 1.5-T magnetic resonance. Am J Clin Nutr, 1990, 51: 953-957.
-
6Zhang ZJ, Yao ZJ, Zhang XB, et al. No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response. Acta Pharmacol Sin, 2003, 24: 235-240.
-
7Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature, 1994, 372: 425-432.
-
8Gong DW, Bi S, Pratley RE, et al. Genomic structure and promoter analysis of the human obese gene. J Biol Chemistry, 1996, 27: 3971-3974.
-
9Ota M, Mori K, Nakashima A, et al. Peripheral injection of risperidone, an atypical antipsychotic, alters the bodyweight gain of rats. Clin Exp Pharmacol Physiol, 2002, 29: 980-989.
-
10Allison DB, Casey DE. Antipsychotic-induced weight gain: a review of the literature. J Clin Psychiatry, 2001, 62 Suppl 7: 22-31.
共引文献1379
-
1王惠颖,徐锦江.不同程度非酒精性脂肪肝与血脂、尿酸及肝功能的相关性[J].慢性病学杂志,2022(2):216-220. 被引量:4
-
2栾贻玫,王云慧.行为疗法干预非酒精性脂肪肝120例效果观察[J].齐鲁护理杂志,2009(9):55-56.
-
3汪骏,姚慧媛,倪娜.2019年某部干部健康体检数据分析[J].武警后勤学院学报(医学版),2020(6):52-54. 被引量:1
-
4李永明.导致非酒精性脂肪肝相关因素及预防对策[J].世界最新医学信息文摘,2020(8):188-189.
-
5张琳娜,魏良洲.肠道益生菌对非酒精性脂肪肝治疗效果的临床研究[J].医学信息,2017,30(11):76-77. 被引量:1
-
6马湖蕊,辛太合,郎枫.痰热清治疗脂肪肝临床观察[J].医学信息(医学与计算机应用),2014,0(9):199-199. 被引量:1
-
7黄雪芳,宋磊,吴胜利,伊力哈木,黄丽娟,朱玉婧,乙丰收,张明涛.2型糖尿病合并非酒精性脂肪肝与肥胖、脂代谢和胰岛素抵抗相关性研究[J].医学信息(医学与计算机应用),2014,0(7):387-387.
-
8肖娴,吕广武,陈超,徐静.血清甘胆酸对非酒精性脂肪肝患者肝脏早期损害的评价[J].世界临床医学,2017,11(15):39-39. 被引量:3
-
9陈爱春,熊闽春.脂肪肝与血糖、血脂及肝功能的关系研究[J].江西医药,2006,41(S1):1086-1088. 被引量:3
-
10梅青.二甲双胍治疗2型糖尿病合并非酒精性单纯性脂肪性肝病的疗效分析[J].实用药物与临床,2006,9(6):346-347. 被引量:2
同被引文献59
-
1范建高,朱军,李新建,李锐,戴菲,宋晓敏,陈兰,李锋,陈世耀.上海市成人脂肪肝患病率及其危险因素流行病学调查[J].中华肝脏病杂志,2005,13(2):83-88. 被引量:582
-
2周永健,李瑜元,聂玉强,黄健,石胜利,李永强,杜艳蕾.肿瘤坏死因子-α基因多态性与非酒精性脂肪性肝病的关系[J].中华消化杂志,2006,26(5):311-314. 被引量:14
-
3樊锦秀,金国健,朱慧民,王爱华,张黎明,陈琪.老年人非酒精性脂肪肝与载脂蛋白E基因多态性关系的研究[J].中华老年医学杂志,2006,25(6):428-430. 被引量:7
-
4刘珉,刘伟,郑升,张宏利,骆天红,罗敏.乙酰辅酶A羧化酶β基因多态性与2型糖尿病易感性关系的初步研究[J].中国糖尿病杂志,2006,14(4):255-257. 被引量:6
-
5Day CP. The potential roal of genes in nonalcoholic fatty liver disease [J]. Clin Liver Dis,2004,8(3) :673-691.
-
6Narnikawa C, Shu-Ping Z, Vyselaar JR, et al. Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis [J]. J Hepatol,2004, 40(5) :781-786.
-
7Eberle D, Clement K, Meyre D, et al. SREBF-1 gene polymorphism are associated with obesity and type 2 diabetes in French obese and diabetic cohorts [J]. Diabetes,2004,53 ( 8 ) :2153-2157.
-
8Musso G,Gambino R, De Michieli F, et al. Adiponeetin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH [ J]. Hepatology,2008,47 (4) : 1167- 1177.
-
9Bouchard L, Weisnagel S J, Engert JC, et al. Human resistin gene polymorphism is associated with visceral obesity and fasting and oral glucose stimulated C-peptide in the Quebec Family Study[ J]. J Endocrinol Invest, 2004,27 ( 11 ) : 1003-1009.
-
10Younossi ZM, Gorreta F, Ong JG, et al. Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis [ J ]. Liver International, 2005,25 ( 4 ) : 760 -771.
二级引证文献9
-
1杨奎真,唐学兰.几丁聚糖降血脂改善肝功能作用的效果观察与分析[J].国际检验医学杂志,2010,31(11):1272-1273. 被引量:1
-
2朱科伦,朱郇悯,曾文铤,梁建新.非酒精性脂肪肝流行病学的研究进展[J].广州医药,2011,42(4):1-2. 被引量:28
-
3李玉华,赵俊岭,苗蕾.非酒精性脂肪性肝病患者载脂蛋白B基因单核苷酸多态性的基因芯片研究[J].福建医药杂志,2013,35(4):4-6.
-
4李玉华,赵俊岭,葛华.非酒精性脂肪肝基因多态性与环境因素的交互作用分析[J].新疆医科大学学报,2013,36(11):1654-1657. 被引量:3
-
5程勇,王四宝,谢谦,王阳阳,田媛,言红健.水飞蓟宾联合牛磺酸对NASH患者血清IL-18、IL-8、肝酶及血脂水平的影响[J].山东医药,2013,53(42):48-49. 被引量:2
-
6管军,徐烨.青少年非酒精性脂肪肝相关危险因素分析[J].实用肝脏病杂志,2017,20(3):347-349. 被引量:9
-
7田娜娜,林欣琪,祁永芬,林子博,周新凤,刘丽.HFE基因多态性与非酒精性脂肪肝病遗传易感性的Meta分析[J].广东药科大学学报,2017,33(2):235-240. 被引量:2
-
8王玉娇,卢畅,姚定康.非酒精性脂肪性肝病的药物治疗研究进展[J].国际消化病杂志,2018,38(4):233-236. 被引量:6
-
9姚晓敏,倪铭,李越,魏玲,林爱斌,李宏伟.橙皮苷对四环素所致小鼠脂肪肝的保护作用[J].山东医药,2015,55(4):28-29. 被引量:1
-
1卢丹.危重症患者强化胰岛素治疗时的血糖监测[J].中华现代护理杂志,2008,14(22):2431-2432. 被引量:5
-
2樊宇荣.非糖尿病危重病患者强化胰岛素治疗的临床研究[J].浙江临床医学,2007,9(4):546-546.
-
3王凤霞.应激性高血糖临床研究[J].中国中医药现代远程教育,2010,8(9):180-181. 被引量:8
-
4倪婷,李美华,王淑芬.瘦素与脂肪肝的发病关系[J].实用医技杂志,2005,12(08B):2254-2255.
-
5尤传一,吴素芬,朱汉民,吴晔,粱瑞君,陈小平,杨俭英,袁济民.糖尿病骨质疏松与钙代谢调节激素的关系[J].老年医学与保健,1997,3(3):21-22. 被引量:5
-
6胡兴国,张云翔,曾因明.危重病人应激性高血糖的研究进展[J].国外医学(麻醉学与复苏分册),2005,26(3):140-143. 被引量:72
-
7儿童糖尿病酮症酸中毒诊疗指南(2009年版)[J].中华医学信息导报,2009,24(14):20-22. 被引量:3
-
8王庆文.高尿酸血症及其肾损害的治疗[J].肾脏病与透析肾移植杂志,2009(3):247-248. 被引量:6
-
9张丽明,石如海.心肺复苏期间的血糖管理[J].医学综述,2007,13(18):1403-1405. 被引量:2
-
10向志敏,欧燕华,张宏富.38例心肺复苏后早期患者糖代谢失衡治疗体会[J].中国实用医药,2010,5(20):135-136. 被引量:2